Condition: Age-Related Macular Degeneration · Age-related Macular Degeneration (ARMD) · Intermediate AMD · Sponsor: i-Lumen Scientific AUS PTY LTD
The goal of this clinical trial is to characterize the safety and effectiveness of the i-Lumen AMD transpalpebral microcurrent device and therapy in patients with intermediate to advanced nonexudative AMD. Participants will: * Undergo an initial loading regimen, followed by 7 maintenance over the course of 11 months. * Participants will return monthly through Month 14 (3 months post-last treatment) for evaluation and monitoring.
This description comes directly from the study's public registry record.
Meredith Mundy · 408-440-7049 · mmundy@i-lumen.com
Always discuss trial participation with your own doctor first.
| Retina Consultants PC | Manchester, Connecticut, United States | Not Yet Recruiting |
| University Retina & Macula Associates | Lemont, Illinois, United States | Not Yet Recruiting |
| Sierra Eye Associates | Reno, Nevada, United States | Not Yet Recruiting |
| Texas Retina Associates | Fort Worth, Texas, United States | Recruiting |
| Tyler Retina Research Insitute | Tyler, Texas, United States | Recruiting |
| Sydney Eye Hospital | Sydney, New South Wales, Australia | Withdrawn |
| Hobart Eye Surgeons | Hobart, Tasmania, Australia | Withdrawn |
| Adelaide Eye & Retina Centre | Adelaide, Victoria, Australia | Withdrawn |
| Cerulea | East Melbourne, Victoria, Australia | Active Not Recruiting |
| Auckland Eye Limited | Remuera, Auckland, New Zealand | Recruiting |
| Southern Eye Specialist | Christchurch, New Zealand | Recruiting |
| Queens University Belfast / Belfast City Hospital | Belfast, United Kingdom | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06662162